Objectives: To examine the association between psychiatric and non-psychiatric comorbidity and 28-day mortality among patients with psychiatric disorders and COVID-19. Methods: Multicenter observational retrospective cohort study of adult patients with psychiatric disorders hospitalized with laboratory-confirmed COVID-19 at 36 Greater Paris university hospitals (January 2020-May 2021) (n=3,768). First, we searched for different subgroups of patients according to their psychiatric and non-psychiatric comorbidities through cluster analysis. Next, we compared 28-day all-cause mortality rates across the identified clusters, while taking into account sex, age, and the number of medical conditions. Results: We found five clusters of patients with distinct psychiatric and non-psychiatric comorbidity patterns. Twenty-eight-day mortality in the cluster of patients with mood disorders was significantly lower than in other clusters. There were no significant differences in mortality across other clusters. Conclusion: All psychiatric and non-psychiatric conditions may be associated with increased mortality in patients with psychiatric disorders and COVID-19. The lower risk of death among patients with mood disorders might be in line with the potential beneficial effect of certain antidepressants in COVID-19, but requires further research. These findings may help identify at-risk patients with psychiatric disorders who should benefit from vaccine booster prioritization and other prevention measures.

Abstract The antibiotic susceptibility profile was evaluated in 71 Enterobacteriaceae isolates obtained from outpatient urine cultures in July 2010 from two health institutions in Santa Fe, Argentina. The highest rates of antibiotic resistance were observed for ampicillin (AMP) (69%), trimethoprim/sulfamethoxazole (TMS) (33%), and ciprofloxacin (CIP) (25%). Meanwhile, 21% of the isolates were resistant to three or more tested antibiotics families. Thirty integron-containing bacteria (42.3%) were detected, and a strong association with TMS resistance was found. Third generation cephalosporin resistance was detected in only one Escherichia coli isolate, and it was characterized as a blaCMY-2 carrier. No plasmid-mediated quinolone resistance (PMQR) was found. Resistance to fluoroquinolone in the isolates was due to alterations in QRDR regions. Two mutations in GyrA (S83L, D87N) and one in ParC (S80I) were observed in all CIP-resistant E. coli. It was determined to be the main phylogenetic groups in E. coli isolates. Minimum Inhibitory Concentration (MIC) values against nalidixic acid (NAL), levofloxacin (LEV), and CIP were determined for 63 uropathogenic E. coli isolates as MIC50 of 4 μg/mL, 0.03125 μg/mL, and 0.03125 μg/mL, respectively, while the MIC90 values of the antibiotics were determined as 1024 μg/mL, 64 μg/mL, and 16 μg/mL, respectively. An association between the phylogenetic groups, A and B1 with fluoroquinolone resistance was observed. These results point to the importance of awareness of the potential risk associated with empirical treatment with both the families of antibiotics.

Several factors could be responsible for a delay in bacteriological conversion of sputum in patients with pulmonary tuberculosis (pTB) even under proper treatment. We aimed to determine those factors associated with follow-up test compliance and bacteriologic conversion at month two of treatment in patients with pTB who were receiving directly controlled treatment (DOT) in an urban area with low TB burden (notification rate: 14.9 cases/100 000, 2010-2011). We retrospectively analyzed the clinical, demographic, radiological, microbiological and therapeutic characteristics of 196 new smear-positive pTB cases. The proportion of patients who underwent bacteriological examination was 79.1% (155/196) and 74.7% (121/162) at the second and last month of treatment. Smear examinations were significantly more frequent in patients with co-morbidities or receiving DOT in health facilities with laboratory access.. Diabetes (OR 17.4, 95% CI 2.0 - 27.0) and high smear grade (OR 13.8, 95% CI 1.8 - 108.0) were highly associated with persistent positive smears. Cavitation (OR 4.6, 95%, CI 1.1-20.5) and diabetes (OR 3.3, 95% CI 1.1-10.5) were associated with persistent positive cultures. Smear examination results at two months of treatment indicated a sensitivity of 63.9% (23/36) and a specificity of 82.4% (98/119) in relation to culture. The limited predictive value of smear examination relative to culture results indicated the need to find other markers for sputum conversion. Identification of risk factors associated with persistent sputum positivity could contribute to patient care and resource allocation. Prolonged infectiousness in patients with diabetes could indicate the need to review TB control strategies.

Varios factores podrían relacionarse con la demora en la negativización bacteriológica de la tuberculosis pulmonar (TBp), aun con adecuado tratamiento. Para determinar su papel en la negativización bacteriológica al segundo mes de tratamiento, se analizaron retrospectivamente las características clínicas, demográficas, radiológicas, microbiológicas y terapéuticas de 196 casos nuevos de TBp con baciloscopia positiva bajo tratamiento directamente observado (TDO) en un área urbana de baja prevalencia de TB (tasa notificada: 14.9 casos/100 000 habitantes, 2010-2011). El porcentaje de pacientes con exámenes bacteriológicos fue 79.1% (155/196) al segundo mes y 74.7% (121/162) al final del tratamiento; aquellos con comorbilidades o que realizaban TDO en servicios con laboratorio tuvieron porcentajes significativamente mayores. La alta carga bacilar (OR 13.8, 95% IC 1.8-108.0) y la diabetes (OR 7.4, 95% IC 2.0-27.0) se asociaron a la persistencia de baciloscopia positiva; la presencia de cavernas (OR 4.6, 95% IC 1.1-20.5) y diabetes (OR 3.3, 95% IC 1.1-10.5) se relacionaron con la persistencia del cultivo positivo. La sensibilidad de la baciloscopia con respecto al cultivo positivo al segundo mes de tratamiento fue 63.9% (23/36) y su especificidad 82.4% (98/119); el limitado valor predictivo de la baciloscopia sobre los resultados del cultivo evidencia la necesidad de encontrar otros marcadores de esterilización del esputo. La identificación de los factores asociados a la persistencia de la infecciosidad contribuye al cuidado de pacientes y a la asignación de recursos. La prolongada infecciosidad de los pacientes diabéticos indicaría la necesidad de rever las estrategias de control de la TB.

The aim of this work was to study the clinical evolution of a group of elderly people who had a tendency to suffer from bacterial infections, mainly of the respiratory tract, after having added food with Lactobacillus casei, Lactobacillus acidophilus and fructans to their diet, and then to correlate the results obtained with alterations in immunological parameters previously set. Ninety patients who were older than 65 and had a background of recurrent bacterial infections in their respiratory tract were included in this study. Their daily diet was supplemented with a dose of Sancor Bio during winter months in 2007. A clinical analysis was carried out, Lactobacillus spp in faeces were counted, CD4 and CD8 lymphocytes were quantified and the activation of monocytes in peripheral blood was evaluated. In conclusion, the administration of this symbiotic food proved to be biochemical and clinically effective, showing to be a good colony of the intestinal mucose, promoting the principally unspecific immune response, everything correlated with clinical information. All this suggests that this food can be used asa preventive therapy in groups of people who are vulnerable to infections and who have immunological system depletions.

El propósito de este trabajo fue estudiar la evolución clínica de un grupo de adultos mayores, proclives a padecer infecciones bacterianas principalmente de las vías respiratorias, al adicionar a su dieta un alimento simbiótico con Lactobacillus casei, Lactobacillus acidophillus y fructanos y, además, correlacionar los resultados obtenidos con modificaciones en los parámetros inmunológicos medidos. Se incluyeron 90 pacientes adultos mayores de 65 años, todos con antecedentes de infecciones bacterianas recurrentes de las vías respiratorias. Cada individuo suplementó su dieta habitual con una dosis diaria del simbiótico SanCor Bio con fructanos. La administración se realizó durante los meses de época invernal. Se realizó un seguimiento clínico, se hizo recuento de Lactobacillus spp en materia fecal, se cuantificaron subpoblaciones linfocitarias CD4 y CD8 y se evaluó la activación de monocitos en sangre periférica. Se observó disminución de los cuadros virales (gripales) y ausencia de infecciones bacterianas de vías respiratorias; además, aumentó el número de Lactobacillus spp en materia fecal y se estimuló la respuesta inmune principalmente inespecífica. Esto sugiere que dicho simbiótico puede ser utilizado como terapia preventiva en grupos vulnerables a infecciones y con depleciones del sistema inmunológico.